These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7510743)

  • 1. Sensitivity of human leukemia cells in exponential or stationary growth phase to anti-CD5 immunotoxins. Role of intracellular processing events.
    Chignola R; Anselmi C; Franceschi A; Pasti M; Candiani C; Tridente G; Colombatti M
    J Immunol; 1994 Mar; 152(5):2333-43. PubMed ID: 7510743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of ricin B chain in the intracellular trafficking of anti-CD5 immunotoxins.
    Manske JM; Buchsbaum DJ; Vallera DA
    J Immunol; 1989 Mar; 142(5):1755-66. PubMed ID: 2465347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of ligand effects in intracellular trafficking of ricin A chain using anti-ricin hybridomas.
    Kornfeld SB; Leonard JE; Mullen MD; Taetle R
    Cancer Res; 1991 Mar; 51(6):1689-93. PubMed ID: 1998959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Selective elimination of human T-leukemia cells with the use of a conjugate of the A-chain of ricin and a monoclonal antibody against CD5-antigen of T-lymphocytes].
    Tonevitskiĭ AG; Toptygin AIu; Marks U; Filatov AV; Alekseev LP
    Dokl Akad Nauk SSSR; 1989; 307(6):1507-11. PubMed ID: 2480212
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytotoxicity of CD3-ricin A chain immunotoxins in relation to cellular uptake and degradation kinetics.
    van Oosterhout YV; Preijers FW; Wessels HM; de Witte T
    Cancer Res; 1992 Nov; 52(21):5921-5. PubMed ID: 1394218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escape mechanisms of human leukemic cells to long-term immunotoxin treatment in an in vitro experimental model.
    Chignola R; Pasti M; Candiani C; Franceschi A; Anselmi C; Tridente G; Colombatti M
    Int J Cancer; 1995 May; 61(4):535-41. PubMed ID: 7538979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo enhancement of ricin-A chain immunotoxin activity by novel indolizine calcium channel blockers: delayed intracellular degradation linked to lipidosis induction.
    Jaffrézou JP; Levade T; Thurneyssen O; Chiron M; Bordier C; Attal M; Chatelain P; Laurent G
    Cancer Res; 1992 Mar; 52(5):1352-9. PubMed ID: 1737397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of ricin A chain immunotoxin activity by perhexiline on established and fresh leukemic cells.
    Jaffrézou JP; Levade T; Kuhlein E; Thurneyssen O; Chiron M; Grandjean H; Carrière D; Laurent G
    Cancer Res; 1990 Sep; 50(17):5558-66. PubMed ID: 2386962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
    Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC
    Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parameters affecting tumor-specific delivery of anti-CD5 antibody-ricin A chain immunotoxins in vivo.
    Rostaing-Capaillon O; Casellas P
    Cancer Res; 1990 May; 50(10):2909-16. PubMed ID: 1692250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotoxins show rapid entry of diphtheria toxin but not ricin via the T3 antigen.
    Youle RJ; Uckun FM; Vallera DA; Colombatti M
    J Immunol; 1986 Jan; 136(1):93-8. PubMed ID: 3079613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the cytotoxic activity of the immunotoxins with different internalization rate.
    Tonevitsky AG; Agapov II; Mechetner EB; Ershova GV; Toptygin AYu ; Sarma T; Shamshiev AT; Pfueller U
    Biochem Mol Biol Int; 1993 Dec; 31(6):1059-69. PubMed ID: 8193589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a monoclonal antibody coupled to ricin A chain-derived peptides on endothelial cells in vitro: insights into toxin-mediated vascular damage.
    Baluna R; Coleman E; Jones C; Ghetie V; Vitetta ES
    Exp Cell Res; 2000 Aug; 258(2):417-24. PubMed ID: 10896793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of isotype on internalization and cytotoxicity of CD19-ricin A immunotoxins.
    van Oosterhout YV; van den Herik-Oudijk IE; Wessels HM; de Witte T; van de Winkel JG; Preijers FW
    Cancer Res; 1994 Jul; 54(13):3527-32. PubMed ID: 7516821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bispecific anti-CD22/anti-CD3-ricin A chain immunotoxin is cytotoxic to Daudi lymphoma cells but not T cells in vitro and shows both A-chain-mediated and LAK-T-mediated killing.
    Shen GL; Li JL; Vitetta ES
    J Immunol; 1994 Mar; 152(5):2368-76. PubMed ID: 8133047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell surface density of p185(c-erbB-2) determines susceptibility to anti-p185(c-erbB-2)-ricin A chain (RTA) immunotoxin therapy alone and in combination with anti-p170(EGFR)-RTA in ovarian cancer cells.
    Dean GS; Pusztai L; Xu FJ; O'Briant K; DeSombre K; Conaway M; Boyer CM; Mendelsohn J; Bast RC
    Clin Cancer Res; 1998 Oct; 4(10):2545-50. PubMed ID: 9796989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis and properties of CD5-ricin immunotoxin].
    Vikha GV; Uzhinova LD; Kashaeva AZh; Goshev VV; Krylov AV; Baryshnikov AIu; Vasilov RG
    Biull Eksp Biol Med; 1995 Jan; 119(1):76-9. PubMed ID: 7536484
    [No Abstract]   [Full Text] [Related]  

  • 18. Sensitivity and selectivity of ricin toxin A chain-monoclonal antibody 791T/36 conjugates against human tumor cell lines.
    Embleton MJ; Byers VS; Lee HM; Scannon P; Blackhall NW; Baldwin RW
    Cancer Res; 1986 Nov; 46(11):5524-8. PubMed ID: 3489523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immuno-ricin A chain specific for gastric cancer: internalization and its significance].
    Wang F
    Zhonghua Yi Xue Za Zhi; 1992 Jul; 72(7):401-4, 445-6. PubMed ID: 1330228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocytosis and intracellular routing of an antibody-ricin A chain conjugate.
    Calafat J; Molthoff C; Janssen H; Hilkens J
    Cancer Res; 1988 Jul; 48(13):3822-7. PubMed ID: 3132322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.